Clinical Trial Update: ctDNA-MRD Monitoring After Resection in Gastric Cancer

View source ↗

Summary

This clinical trial is evaluating ctDNA-based minimal residual disease monitoring after surgical resection in patients with gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Status: RECRUITING